Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | PPM1B | O75688 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.39 |
| ▸ | KDM4A | O75164 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL631270 | 1.00 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| Ethylene Glycol SCHEMBL29002151 | 0.95 | ALDH1A1 (0.51) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL14674752 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| Succinic Acid SCHEMBL31137819 | 0.89 | CYP1A2 (0.47) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL30773222 | 0.87 | ALDH1A1 (0.49) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL1226562 | 0.86 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL17821007 | 0.86 | ALDH1A1 (0.47) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL846234 | 0.86 | ALDH1A1 (0.47) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL4069043 | 0.85 | CYP1A2 (0.44) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 | |
| SCHEMBL8510382 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KDM4EHPGDMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119563857-A | Tomato extract containing succinyl amino acid, preparation method and application thereof | 北京鸿禧志业科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| WO-2012167243-A1 | COMPOSITIONS AND METHODS OF TREATMENT FOR OBESITY | B & P COMPANY, INC. (US) | 2012-12-06 | — | — | WO | claimed |
| EP-1443954-B1 | TARGETED THROMBOSIS BY TISSUE FACTOR POLYPEPTIDES | SCRIPPS RESEARCH INST (US) | 2010-11-24 | — | — | EP | claimed |
| US-7399743-B2 | Targeted thrombosis | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-07-15 | — | — | US | claimed |
| EP-1443954-A2 | TARGETED THROMBOSIS BY TISSUE FACTOR POLYPEPTIDES | Novartis Pharma GmbH (AT) | 2004-08-11 | — | — | EP | claimed |
| US-20030194400-A1 | Targeted thrombosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-16 | — | — | US | claimed |
| WO-2003035688-A2 | TARGETED THROMBOSIS BY TISSUE FACTOR POLYPEPTIDES | NOVARTIS PHARMA GMBH (AT) | 2003-05-01 | — | — | WO | claimed |
| US-20250367276-A1 | MICROBIOTA ANALOGS OF TUMOR ASSOCIATED ANTIGENS AND USES THEREOF | ISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE (IT) | 2025-12-04 | — | — | US | disclosed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | disclosed |
| US-20250281548-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING EXTRACELLULAR VESICLES AND METHODS THEREOF | WASHINGTON STATE UNIVERSITY | 2025-09-11 | — | — | US | disclosed |
| US-12312627-B2 | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds | GENOMATICA, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| CN-119563857-A | Tomato extract containing succinyl amino acid, preparation method and application thereof | 北京鸿禧志业科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119563857-A | Tomato extract containing succinyl amino acid, preparation method and application thereof | 北京鸿禧志业科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-7399743-B2 | Targeted thrombosis | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-07-15 | — | — | US | disclosed |
| EP-1443954-A2 | TARGETED THROMBOSIS BY TISSUE FACTOR POLYPEPTIDES | Novartis Pharma GmbH (AT) | 2004-08-11 | — | — | EP | disclosed |
| US-20030194400-A1 | Targeted thrombosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-16 | — | — | US | disclosed |
| US-6562958-B1 | Nucleotide sequences coding polypeptide for use in the treatment and prevention of infections | GENOME THERAPEUTICS CORPORATION | 2003-05-13 | — | — | US | disclosed |
| WO-2003035688-A2 | TARGETED THROMBOSIS BY TISSUE FACTOR POLYPEPTIDES | NOVARTIS PHARMA GMBH (AT) | 2003-05-01 | — | — | WO | disclosed |
| EP-1144446-A1 | PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000031129-A1 | PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) | 2000-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | ALDH1A1 110/4885KDM4E 374/4885HPGD 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.